Middle East Molecular Diagnostics Market

Home Healthcare And Pharmaceutical Middle East Molecular Diagnostics Market

Middle East Molecular Diagnostics Market, By Product (Systems, Kits & Consumables, Software & Other Products); By Testing Location (Laboratory Testing, Point-of-Care Testing); By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (IHC), Other Technologies); By Application (Core Molecular Diagnostics, Reproductive Genetics, Companion Diagnostics (CDx), Liquid Biopsy, Other Applications); By End User (Hospitals, Diagnostic Centers, Out-Patient Clinics/General Practitioners, Research Laboratories, Other End Users); By Country (Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar, Rest of Middle East), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

Published Date: March 2023
Report ID: BWC23250
Available Format: PDF
Page: 240

Report Overview

An increasing focus on diagnosing and treating rising number of infectious disease and cancer affected patients and growing awareness and acceptance of personalized medicines in the region are expected to boost the growth of the Middle East molecular diagnostics market during the forecast period between 2023 and 2029.

Middle East Molecular Diagnostics Market - Industry Trends & Forecast Report, 2029

Middle East molecular diagnostics market size was estimated to be worth USD 527.82 million in 2022. During the forecast period between 2023 and 2029, the Middle East molecular diagnostics market size is projected to grow at a CAGR of 8.3% reaching a value of USD 919.34 million by 2029. Major growth factors for the Middle East molecular diagnostics market include aging population, rising communicable and non-communicable illness prevalence, improvements in molecular diagnostics technology, and increasing expenditures on healthcare.

Middle East Molecular Diagnostics Market

Middle East Molecular Diagnostics Market – Overview

The growing healthcare industry makes use of technology to diagnose and monitor complex conditions, detect risk, and, most importantly, select the most tailored treatments and therapies for individual patients. molecular diagnostics is the study of how individuals express their genes as proteins and the application of medical and microbiological technology in medical imaging science to examine biological markers residing in the proteome and genome. For decades, molecular diagnostics has been regarded as a superior tool for reaching the goal of faster disease diagnosis with fewer complications. The demand for these procedures is growing, especially for diagnosing infectious diseases.

Middle East Molecular Diagnostics Market

Growth Drivers

Increasing Number of Infectious Disease-related Clinical Trials

With the rising burden of communicable diseases, the number of clinical trials in Middle Eastern countries has also spiked. According to the data published by the Clinical Trials Arena, “the Middle East has seen an 888% increase in the number of infectious disease trials taking place over the past decade, the largest increase for any region worldwide.” The data also revealed that Iran hosted the highest number of trials in the area in 2020, accounting for 79.3% of all trials. With 9.1% and 3.4%, respectively, of the region's trials taking place, Israel and Saudi Arabia came in second and third.

Restraints

High Cost of Molecular Diagnostics

Molecular approaches typically cost more than more common conventional approaches. Some labs might find the expense of supplies and equipment to be prohibitive. Furthermore, certain clinical laboratories might not have the specific area needed for molecular amplification techniques. Additionally, the market growth is severely constrained by inadequate reimbursements. Obtaining private health insurance to cover diagnostic testing is a challenge for the majority of diagnostic firms.

Middle East Molecular Diagnostics Market

Segmental Coverage

Middle East Molecular Diagnostics Market – By Product

Based on product, the Middle East molecular diagnostics market is segregated into systems, kits & consumables, software, and other product segments. The kits and consumables segment holds the highest market share. A full polymerase chain reaction (PCR) typically needs five basic reagents, including a DNA template, forward and reverse primers, DNA polymerase, deoxynucleotide triphosphates (dNTPs), and reaction buffer. Standard reagents aid in obtaining reliable and timely results. It is envisaged that standardized outcomes, increased efficacy, and cost-effectiveness will encourage market expansion.

Middle East Molecular Diagnostics Market – By Testing Location

Based on testing location, the Middle East molecular diagnostics market is segmented into laboratory testing and point-of-care testing. Laboratory testing accounts for the highest share in the Middle East molecular diagnostics market. Lab tests have historically been utilized in hospitals and diagnostic facilities and are widely acknowledged. Another significant factor projected to drive the market is a growth in the number of efforts done by the government to provide various services, such as reimbursement for diagnostic tests.

Middle East Molecular Diagnostics Market Size

Middle East Molecular Diagnostics Market – By Technology

Based on technology, the Middle East molecular diagnostics market is segmented into polymerase chain reaction (PCR), next-generation sequencing, isothermal nucleic acid amplification technology (INAAT), microarray, in-situ hybridization (ISH), immunohistochemistry (IHC), and other technologies. The polymerase chain reaction (PCR) technology accounts for the largest market share. While a COVID-19 infection is still in its early stages, fast antigen testing frequently results in false negatives and false positives. In contrast, PCR assays are far less likely to have similar problems. Its higher accuracy compared to its counterparts play a crucial factor in propelling its market growth.

Middle East Molecular Diagnostics Market – By Application

Based on application, the Middle East molecular diagnostics market is segmented into core molecular diagnostics, reproductive genetics, companion diagnostics (CDX), liquid biopsy, and other applications. The core molecular diagnostics segment holds the highest share in the Middle East molecular diagnostics market. The increased use of molecular testing in laboratories to treat illnesses is primarily responsible for this market segment's expansion. The majority of the Middle East's molecular diagnostics market is serviced by a wide number of inclusive core molecular diagnostics applications.

Middle East Molecular Diagnostics Market – By End Users

Based on end users, the Middle East molecular diagnostics market is segmented into hospitals, diagnostic centers, outpatient clinics/general practitioners, research laboratories, and other end users. The hospital segment accounts for the highest market share. The increasing number of patients approaching hospitals for regular checkups and in case of suffering from communicable diseases contributes to the growing demand for molecular diagnostics tools in hospitals. Hospitals also offer real-time assistance from health professionals as well as quick commencement of treatments which is contributing to its market growth.

Middle East Molecular Diagnostics Market – By Country

The Middle East molecular diagnostics market covers the following major countries: Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar and the rest of Middle East. Saudi Arabia dominates the Middle East molecular diagnostics market owing to the increasing prevalence of communicable diseases in this region. To stop the spread of infectious illnesses including seasonal flu, tuberculosis (TB), yellow fever, and others that are becoming more common in Saudi Arabia, the government is setting up diagnostic facilities. Eventually, this led to a notable increase in the molecular diagnostics market in the area.

Competitive Landscape

Major competitors in the Middle East molecular diagnostics market include Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In September 2022 – OpGen, Inc., a US-based molecular microbiology solutions company, announced that its subsidiary Curetis GmbH signed a distribution agreement for the distribution of Unyvero systems in Qatar and the UAE with Leader Life Sciences through their trading firm Leader Medical Supplies Trading LLC, a member of the Leader Healthcare Group.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD Million
Market Coverage	Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar, Rest of Middle East
Product/ Service Segmentation	Product, Testing Location, Technology, Application, End User, Country
Key Players	Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.

By Product

Systems
Kits & Consumables
Software
Other Products

By Testing Location

Laboratory Testing
Point-of-Care Testing

By Technology

Polymerase Chain Reaction (PCR)
Next-Generation Sequencing
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarray
In-Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Other Technologies

By Application

Core Molecular Diagnostics
Reproductive Genetics
Companion Diagnostics (CDx)
Liquid Biopsy
Other Applications

By End User

Hospitals
Diagnostic Centres
Out-Patient Clinics/General Practitioners
Research Laboratories
Other End Users

By Country

Saudi Arabia
UAE
Lebanon
Bahrain
Oman
Qatar
Rest of Middle East

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Middle East Molecular Diagnostics Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing Prevalence of Infectious Diseases and Various Types of Cancer in the Middle East
    2. Increase in Awareness and Acceptance of Personalized Medicines in the Middle East
    3. Significant External Funding for Executing Research and Development Exercises
  2. Restraints
    1. Uncertain Reimbursement Scenario
    2. Lack of High-Complexity Testing Centres in the Middle East
  3. Opportunities
    1. Massive Scope for Adoption of Molecular Diagnostics
    2. Rise of Next-Generation Ultrasensitive Molecular Diagnostics
    3. Novel Revenue Streams
  4. Challenges
    1. COVID-19 Impact on Middle East Molecular Diagnostics
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Middle East Molecular Diagnostics Market Overview
1. Market Size & Forecast by Value, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
    1. Systems
    2. Kits & Consumables
    3. Software
    4. Other Product
  2. By Testing Location
    1. Laboratory Testing
    2. Point-of-Care Testing
  3. By Technology
    1. Polymerase Chain Reaction (PCR)
    2. Next-Generation Sequencing
    3. Isothermal Nucleic Acid Amplification Technology (INAAT)
    4. Microarray
    5. In-Situ Hybridization (ISH)
    6. Immunohistochemistry (IHC)
    7. Other Technologies
  4. By Application
    1. Core Molecular Diagnostics
    2. Reproductive Genetics
    3. Companion Diagnostics (CDx)
    4. Liquid Biopsy
    5. Other Applications
  5. By End User
    1. Hospitals
    2. Diagnostic Centres
    3. Out-Patient Clinics/General Practitioners
    4. Research Laboratories
    5. Other End Users
  6. By Country
    1. Saudi Arabia
    2. UAE
    3. Lebanon
    4. Bahrain
    5. Oman
    6. Qatar
    7. Rest of Middle East
Saudi Arabia Molecular Diagnostics Market
1. 1. Market Size & Forecast by Value, 2019–2 029
  2. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
UAE Molecular Diagnostics Market
1. 1. Market Size & Forecast by Value, 2019–2 029
  2. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Lebanon Molecular Diagnostics Market
1. Market Size & Forecast by Value, 2019–2 029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Bahrain Molecular Diagnostics Market
1. Market Size & Forecast by Value, 2019–2 029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Oman Molecular Diagnostics Market
1. Market Size & Forecast by Value, 2019–2 029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Qatar Molecular Diagnostics Market
1. Market Size & Forecast by Value, 2019–2 029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Rest of Middle East Molecular Diagnostics Market
1. Market Size & Forecast by Value, 2019–2 029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Testing Location
  3. By Technology
  4. By Application
  5. By End Users
Competitive Landscape
1. List of Key Players and Their Offerings
2. Middle East Molecular Diagnostics Company Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Development (Mergers, Acquisitions, Partnerships, and others)
Impact of Covid-19 on Middle East Molecular Diagnostics Market
Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
1. Abbott
2. Agilent Technologies, Inc.
3. bioMerieux SA
4. Babirus Medical Equipment LLC
5. Bio-Rad Laboratories, Inc.
6. Danaher
7. F. Hoffmann-La Roche Ltd.
8. Guardant Health
9. Illumina, Inc.
10. QIAGEN N.V.
11. Thermo Fisher Scientific Inc
12. Other prominent players.
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumption & Limitation

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Figure 1 Middle East Molecular Diagnostics Market Segmentation

Figure 2 Middle East Molecular Diagnostics Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 5 Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 6 Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 7 Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 8 Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 9 Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 10 Middle East Molecular Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 11 Saudi Arabia Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 12 Saudi Arabia Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 13 Saudi Arabia Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 14 Saudi Arabia Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 15 Saudi Arabia Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 16 Saudi Arabia Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 17 UAE Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 18 UAE Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 19 UAE Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 20 UAE Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 21 UAE Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 22 UAE Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 23 Lebanon Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 24 Lebanon Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 25 Lebanon Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 26 Lebanon Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 27 Lebanon Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 28 Lebanon Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 29 Bahrain Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 30 Bahrain Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 31 Bahrain Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 32 Bahrain Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 33 Bahrain Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 34 Bahrain Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 35 Oman Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 36 Oman Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 37 Oman Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 38 Oman Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 39 Oman Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 40 Oman Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 41 Qatar Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 42 Qatar Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 43 Qatar Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 44 Qatar Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45 Qatar Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 46 Qatar Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 47 Rest of Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 48 Rest of Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 49 Rest of Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 50 Rest of Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 51 Rest of Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 52 Rest of Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1 Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 2 Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 3 Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4 Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 5 Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 6 Middle East Molecular Diagnostics Market Size, By Country, By Value, 2019–2029

Table 7 Saudi Arabia Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 8 Saudi Arabia Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 9 Saudi Arabia Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 10 Saudi Arabia Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 11 Saudi Arabia Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 12 UAE Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 13 UAE Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 14 UAE Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 15 UAE Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 16 UAE Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 17 Lebanon Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 18 Lebanon Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 19 Lebanon Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 20 Lebanon Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 21 Lebanon Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 22 Bahrain Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 23 Bahrain Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 24 Bahrain Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 25 Bahrain Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 26 Bahrain Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 27 Oman Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 28 Oman Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 29 Oman Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 30 Oman Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 31 Oman Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 32 Qatar Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 33 Qatar Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 34 Qatar Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 35 Qatar Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 36 Qatar Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 37 Rest of Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 38 Rest of Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 39 Rest of Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 40 Rest of Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 41 Rest of Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 42 Abbott Company Overview

Table 43 Abbott Financial Overview

Table 44 Agilent Technologies, Inc. Company Overview

Table 45 Agilent Technologies, Inc. Financial Overview

Table 46 bioMerieux SA Company Overview

Table 47 bioMerieux SA Financial Overview

Table 48 Babirus Medical Equipment LLC Company Overview

Table 49 Babirus Medical Equipment LLC Financial Overview

Table 50 Bio-Rad Laboratories, Inc. Company Overview

Table 51 Bio-Rad Laboratories, Inc. Financial Overview

Table 52 Danaher Company Overview

Table 53 Danaher Financial Overview

Table 54 F. Hoffmann-La Roche Ltd. Company Overview

Table 55 F. Hoffmann-La Roche Ltd. Financial Overview

Table 56 Guardant Health Company Overview

Table 57 Guardant Health Financial Overview

Table 58 Illumina, Inc. Company Overview

Table 59 Illumina, Inc. Financial Overview

Table 60 QIAGEN N.V. Company Overview

Table 61 QIAGEN N.V. Financial Overview

Table 62 Thermo Fisher Scientific Inc Company Overview

Table 63 Thermo Fisher Scientific Inc Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current market size of Middle East Molecular Diagnostics Market?

Ans: Middle East Molecular Diagnostics Market size was estimated at USD 527.82 million in 2022.

2. What are the major factors driving the growth of Middle East Molecular Diagnostics Market?

Ans: Major factors driving the growth of Middle East Molecular Diagnostics Market include increase in awareness and acceptance of personalized medicines in the middle east and significant external funding for executing research and development exercises.

3. Which segment accounted for the highest share in Middle East Molecular Diagnostics Market by end user?

Ans: The hospitals segment held the highest market share in the Middle East Molecular Diagnostics Market by end user.

4. Which is the fastest growing country in Middle East Molecular Diagnostics Market?

Ans: Saudi Arabia is expected to grow at the fastest rate in Middle East Molecular Diagnostics Market during the forecast period between 2023 and 2029.

5. Name the key players in Middle East Molecular Diagnostics Market.

Ans: Key players in Middle East Molecular Diagnostics Market include Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc.

PLACE AN ORDER

SINGLE USER LICENSE
$ 3599
GROUP LICENSE
$ 4000
ENTERPRISE LICENSE
$ 4500
EXCEL DATA PACK
$ 2100

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Middle East Molecular Diagnostics Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

1. What is the current market size of Middle East Molecular Diagnostics Market?

2. What are the major factors driving the growth of Middle East Molecular Diagnostics Market?

3. Which segment accounted for the highest share in Middle East Molecular Diagnostics Market by end user?

4. Which is the fastest growing country in Middle East Molecular Diagnostics Market?

5. Name the key players in Middle East Molecular Diagnostics Market.

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security